Enhanced antitumor effect of targeted nanoliposomal bleomycin
- 15 June 2017
- journal article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 90 (5) , 953-961
Abstract
Folate receptor (FR)‐mediated drug delivery is a promising approach for active targeting of drugs to the FR‐positive tumor cells. Bleomycin (BLM) is an antitumor antibiotic with poor therapeutic activity as a result of its limited diffusion into tumor cells. The aim of this study was to investigate whether FR‐targeted PEGylated nanoliposomes (FPNL) can effectively deliver BLM to tumor cells and enhance its in vitro and in vivo efficacy. FPNL and PNL (non‐targeted) were prepared by thin film hydration method, and their physiochemical properties, cellular uptake, tissue distribution and tumor inhibitory effects were investigated. In Lewis lung cancer (LLC1) cells, FPNL containing BLM showed 2.38‐fold and 3.26‐fold higher cytotoxicity compared to PNL‐BLM and free BLM, respectively. Moreover, the uptake of FPNL by these cells was increased as compared to the PNL. Furthermore, FPNL showed significantly higher tumor distribution of BLM in the LLC1 cells and more tumor inhibition efficacy compared to free BLM and PNL. Both formulations of nanoliposomes had longer plasma half‐life than that of free BLM. Therefore, FPNL may be suitable carriers for targeted drug delivery to FR‐positive tumor cells.Keywords
Funding Information
- postgraduate office
- Pasteur Institute of Iran
This publication has 31 references indexed in Scilit:
- Preparation, characterization, and in vitro evaluation of bleomycin‐containing nanoliposomesChemical Biology & Drug Design, 2016
- Bleomycin in octaarginine-modified fusogenic liposomes results in improved tumor growth inhibitionCancer Letters, 2013
- Bleomycin-Induced Raynaud's Phenomenon After Single-Dose Exposure: Risk Factors and Treatment With Intravenous Iloprost InfusionJournal of Clinical Oncology, 2013
- Targeting Her-2+ Breast Cancer Cells with Bleomycin Immunoliposomes Linked to LLOMolecular Pharmaceutics, 2012
- Preparation of pingyangmycin PLGA microspheres and related in vitro/in vivo studiesInternational Journal of Pharmaceutics, 2010
- Effective Tumor Treatment Using Optimized Ultrasound-Mediated Delivery of BleomycinUltrasound in Medicine & Biology, 2008
- The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?The International Journal of Biochemistry & Cell Biology, 2008
- A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitroAdvanced Drug Delivery Reviews, 2004
- Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progressDrug Discovery Today, 2004
- Liposomal Bleomycin: Increased Therapeutic Activity and Decreased Pulmonary Toxicity in MiceDrug Delivery, 2001